Q-L. Choo

1.9k total citations · 2 hit papers
10 papers, 1.5k citations indexed

About

Q-L. Choo is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Q-L. Choo has authored 10 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 6 papers in Epidemiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Q-L. Choo's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Q-L. Choo is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Q-L. Choo collaborates with scholars based in Netherlands, United States and Japan. Q-L. Choo's co-authors include Michael Houghton, George Kuo, J. Guardia, Rafael Esteban, Vı́ctor Vargas, Marı́a Buti, Joan Genescà, Antonio González, M Roget and P.N. Lelie and has published in prestigious journals such as The Lancet, The Journal of Immunology and Journal of Hepatology.

In The Last Decade

Q-L. Choo

10 papers receiving 1.4k citations

Hit Papers

HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN 1989 2026 2001 2013 1989 1989 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Q-L. Choo Netherlands 8 1.4k 1.2k 133 111 95 10 1.5k
George Kuo United States 6 1.6k 1.2× 1.4k 1.1× 253 1.9× 56 0.5× 133 1.4× 7 1.8k
J Duval France 16 1.1k 0.8× 915 0.7× 102 0.8× 64 0.6× 254 2.7× 23 1.4k
Ruth L. Co United States 14 1.4k 1.0× 1.3k 1.0× 50 0.4× 40 0.4× 141 1.5× 21 1.5k
Terryl J. Ortego United States 5 1.2k 0.9× 1.1k 0.9× 53 0.4× 43 0.4× 337 3.5× 5 1.5k
P.J. van Exel‐Oehlers Netherlands 6 759 0.6× 667 0.5× 134 1.0× 33 0.3× 60 0.6× 7 816
Alexandra L. Gibas United States 9 1.9k 1.4× 1.9k 1.5× 58 0.4× 53 0.5× 350 3.7× 12 2.3k
A. Bismuth France 19 1.3k 0.9× 1.1k 0.9× 55 0.4× 69 0.6× 25 0.3× 38 1.8k
Olle Reichard Sweden 21 1.7k 1.2× 1.5k 1.2× 33 0.2× 45 0.4× 233 2.5× 39 1.9k
J Guàrdia Spain 17 621 0.5× 596 0.5× 47 0.4× 20 0.2× 72 0.8× 93 858
Kiyohiko Kurai Japan 6 2.0k 1.5× 1.7k 1.4× 269 2.0× 19 0.2× 331 3.5× 17 2.1k

Countries citing papers authored by Q-L. Choo

Since Specialization
Citations

This map shows the geographic impact of Q-L. Choo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q-L. Choo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q-L. Choo more than expected).

Fields of papers citing papers by Q-L. Choo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Q-L. Choo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q-L. Choo. The network helps show where Q-L. Choo may publish in the future.

Co-authorship network of co-authors of Q-L. Choo

This figure shows the co-authorship network connecting the top 25 collaborators of Q-L. Choo. A scholar is included among the top collaborators of Q-L. Choo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Q-L. Choo. Q-L. Choo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Houghton, Michael, Q-L. Choo, George Kuo, et al.. (1995). Prospects for prophylactic and therapeutic hepatitis C virus vaccines.. PubMed. 25. 237–43. 5 indexed citations
2.
Erickson, Ann L., Michael Houghton, Q-L. Choo, et al.. (1993). Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.. The Journal of Immunology. 151(8). 4189–4199. 114 indexed citations
3.
Poel, C.L. van der, Dorine Bresters, H. W. Reesink, et al.. (1992). Early Antihepatitis C Virus Response with Second—Generation C200/C22 ELISA. Vox Sanguinis. 62(4). 208–212. 49 indexed citations
4.
Bresters, Dorine, H. T. M. Cuypers, H. W. Reesink, et al.. (1992). Enhanced Sensitivity of a Second Generation ELISA for Antibody to Hepatitis C Virus. Vox Sanguinis. 62(4). 213–217. 39 indexed citations
5.
Poel, Chris van der, H.T.M. Cuypers, H. W. Reesink, et al.. (1991). Risk factors in hepatitis C virus‐infected blood donors. Transfusion. 31(8). 777–779. 44 indexed citations
6.
Makris, Michael, F E Preston, D. R. Triger, et al.. (1990). Hepatitis C antibody and chronic liver disease in haemophilia. The Lancet. 335(8698). 1117–1119. 195 indexed citations
7.
Katayama, Toru, Shu Kikuchi, Izumu Saito, et al.. (1990). BLOOD SCREENING FOR NON‐A, NON‐B HEPATITIS BY HEPATITIS C VIRUS ANTIBODY ASSAY. Transfusion. 30(4). 374–376. 36 indexed citations
8.
Esteban, Rafael, Antonio González, M Roget, et al.. (1989). HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN. The Lancet. 334(8658). 294–297. 751 indexed citations breakdown →
9.
Poel, C.L. van der, P.N. Lelie, Q-L. Choo, et al.. (1989). ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS. The Lancet. 334(8658). 297–298. 260 indexed citations breakdown →
10.
Nelles, M J, Robert K. DiNello, Quan Shen, et al.. (1989). Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to hepatitis C (non-A, non-B hepatitis) virus. Journal of Hepatology. 9. S187–S187. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026